Santhera Pharmaceuticals Holding AG (SPHDF)
USD 9.42
(0.0%)
USD 9.42
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 29.76 Million USD | -46.89% |
| 2022 | 56.05 Million USD | 3.62% |
| 2021 | 54.09 Million USD | -32.81% |
| 2020 | 80.5 Million USD | 29.95% |
| 2019 | 61.95 Million USD | 11.92% |
| 2018 | 55.35 Million USD | 1.57% |
| 2017 | 54.5 Million USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 26.34 Million USD | 11.88% |
| 2024 Q1 | 26.23 Million USD | -11.85% |
| 2023 Q1 | 44.69 Million USD | -20.26% |
| 2023 FY | 29.76 Million USD | -46.89% |
| 2023 Q4 | 29.76 Million USD | 29.89% |
| 2023 Q3 | 22.91 Million USD | -56.15% |
| 2023 Q2 | 52.25 Million USD | 16.92% |
| 2022 Q2 | 45.73 Million USD | 0.0% |
| 2022 FY | 56.05 Million USD | 3.62% |
| 2022 Q4 | 56.05 Million USD | 26.23% |
| 2022 Q3 | 44.4 Million USD | -2.92% |
| 2021 Q2 | 46.91 Million USD | 0.0% |
| 2021 FY | 54.09 Million USD | -32.81% |
| 2021 Q4 | 54.09 Million USD | 0.0% |
| 2020 FY | 80.5 Million USD | 29.95% |
| 2020 Q4 | 80.5 Million USD | 0.0% |
| 2020 Q2 | 65.05 Million USD | 0.0% |
| 2019 Q2 | 65.69 Million USD | 0.0% |
| 2019 FY | 61.95 Million USD | 11.92% |
| 2019 Q4 | 61.95 Million USD | 0.0% |
| 2018 FY | 55.35 Million USD | 1.57% |
| 2017 FY | 54.5 Million USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 27.755% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -622.16% |
| SQZ Biotechnologies Company | 27.47 Million USD | -8.358% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 31.369% |
| Mesoblast Limited | 118.7 Million USD | 74.922% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -3039.096% |
| Genus plc | 233.1 Million USD | 87.23% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -915.809% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -2115.503% |
| Marizyme, Inc. | 18.71 Million USD | -59.034% |
| ContraFect Corporation | 2.88 Million USD | -933.222% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -3868.952% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -21870.476% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -1958.131% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -1179.781% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -426.074% |
| MultiCell Technologies, Inc. | 202.58 USD | -14693916.685% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 48.221% |
| EV Biologics, Inc. | 1.49 Million USD | -1891.445% |
| Q BioMed Inc. | 4.1 Million USD | -624.265% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 10.072% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -4624.365% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -2323.322% |
| Biomind Labs Inc. | 735.54 Thousand USD | -3946.967% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 82.648% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -129.031% |
| Skye Bioscience, Inc. | 4.61 Million USD | -544.971% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -3251.914% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -20934.172% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -407.012% |
| IMV Inc. | 28.88 Million USD | -3.058% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -115639.877% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -1218.074% |
| GB Sciences, Inc. | 1.75 Million USD | -1591.981% |
| Alpha Cognition Inc. | 1.22 Million USD | -2339.186% |
| HST Global, Inc. | 98.31 Thousand USD | -30176.08% |
| CSL Limited | 12.18 Billion USD | 99.756% |
| Halberd Corporation | 150 Thousand USD | -19744.759% |
| Enzolytics Inc. | 996.33 Thousand USD | -2887.655% |
| Resverlogix Corp. | 6.49 Million USD | -358.591% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -6133.956% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -11546.35% |
| argenx SE | 20 Million USD | -48.836% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 34.664% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -998.944% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -291021.164% |
| Genscript Biotech Corporation | 417.73 Million USD | 92.874% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -14737.869% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -1141.475% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -12882.254% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 55.994% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -883.65% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -8175.316% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -46.434% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -19924.445% |
| BioStem Technologies, Inc. | 4.71 Million USD | -531.809% |
| ONE Bio Corp. | 19.71 Million USD | -50.987% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -11798.194% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -11868.132% |
| Agentix Corp. | 50 Thousand USD | -59434.278% |
| LadRx Corporation | 33.6 Thousand USD | -88476.858% |
| Cell Source, Inc. | 9.25 Million USD | -221.662% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -3836.39% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -3836.39% |
| NovAccess Global Inc. | 2.19 Million USD | -1253.126% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -320.867% |
| Itoco Inc. | 228.37 Thousand USD | -12934.211% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -14009.321% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -497.374% |
| Kadimastem Ltd | 891.22 Thousand USD | -3240.021% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -7307.543% |
| CytoDyn Inc. | 30.07 Million USD | 1.027% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -6046.629% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -8360.251% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -280.656% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -24199.705% |
| Rebus Holdings, Inc. | 310 Thousand USD | -9502.303% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -528.624% |
| International Stem Cell Corporation | 4.17 Million USD | -612.473% |
| Bioxytran, Inc. | 1.92 Million USD | -1446.345% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -47593.812% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -1264.902% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -257.95% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -246.734% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -1813.696% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -11007.141% |
| Neutra Corp. | 54.15 Thousand USD | -54865.542% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -1526.62% |
| PureTech Health plc | 25.51 Million USD | -16.679% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -2331.507% |
| IXICO plc | 472.02 Thousand USD | -6206.29% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -92.034% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 52.191% |
| CSL Limited | 12.18 Billion USD | 99.756% |
| Cellectis S.A. | 92.77 Million USD | 67.915% |